BioAge Labs Inc (NASDAQ:BIOA)’s traded shares stood at 0.31 million during the last session. At the close of trading, the stock’s price was $4.63, to imply an increase of 5.95% or $0.26 in intraday trading. The BIOA share’s 52-week high remains $26.62, putting it -474.95% down since that peak but still an impressive 16.85% since price per share fell to its 52-week low of $3.85.
BioAge Labs Inc (NASDAQ:BIOA) trade information
After registering a 5.95% upside in the last session, BioAge Labs Inc (BIOA) has traded red over the past five days. The 5-day price performance for the stock is 2.89%, and -6.84% over 30 days. With these gigs, the year-to-date price performance is -20.03%.
The extremes give us $7 and $45 for target low and target high price respectively. As such, BIOA has been trading -871.92% off suggested target high and -51.19% from its likely low.
BIOA Dividends
BioAge Labs Inc has its next earnings report out in April. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
We also have iShares Russell 2000 ETF and Principal Small Cap Growth Fd I as the top two Mutual Funds with the largest holdings of the BioAge Labs Inc (BIOA) shares. Going by data provided on Dec 31, 2024 , iShares Russell 2000 ETF holds roughly 330.75 shares. This is just over 0.92% of the total shares, with a market valuation of $1.53 million. Data from the same date shows that the other fund manager holds a little less at 274.39, or 0.77% of the shares, all valued at about 1.27 million.
